Matros Richard K
MATROS RICHARD K, CHAIR, CEO, PRES, reported an open-market or private sale at Sabra Health Care REIT, Inc. involving 200000.000000 shares for an estimated $4166000.00. Reported holdings after the transaction were 1657686.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,857,686 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
SBRA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001184158-26-000016 Common Stock
- Transaction date
- Sep 08, 2026 Filed Sep 09, 2026, 11:03 PM · 1d delay
- Shares
- 200,000 sh $20.83 per share
- Estimated value
- -$4.16M Computed from shares × price
- Holdings after
- 1,657,686 sh Indirect · By R&A Matros Revocable Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chair, CEO and President
- F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026.
- F2
The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.66 to $20.94, inclusive. The Reporting Person undertakes to provide…
- F3
Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
0 other transactions
0 recent txs